Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Stephen Oxley bought 27 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The stock was acquired at an average cost of GBX 1,451 ($18.33) per share, for a total transaction of £391.77 ($494.97).
Stephen Oxley also recently made the following trade(s):
- On Wednesday, November 27th, Stephen Oxley acquired 7,407 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 1,343 ($16.97) per share, with a total value of £99,476.01 ($125,680.37).
Johnson Matthey Stock Up 1.0 %
Shares of JMAT stock traded up GBX 14.22 ($0.18) during trading hours on Friday, hitting GBX 1,463.22 ($18.49). 984,651 shares of the company's stock traded hands, compared to its average volume of 556,306. The stock's fifty day simple moving average is GBX 1,384.37 and its two-hundred day simple moving average is GBX 1,479.94. Johnson Matthey PLC has a 12-month low of GBX 1,295.54 ($16.37) and a 12-month high of GBX 1,917.07 ($24.22). The stock has a market cap of £2.45 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its quarterly earnings data on Wednesday, November 27th. The company reported GBX 57.40 ($0.73) earnings per share for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. On average, analysts expect that Johnson Matthey PLC will post 173.4112903 EPS for the current year.
Johnson Matthey Cuts Dividend
The company also recently disclosed a dividend, which was paid on Tuesday, February 4th. Investors of record on Thursday, December 5th were issued a GBX 22 ($0.28) dividend. The ex-dividend date of this dividend was Thursday, December 5th. This represents a yield of 1.47%. Johnson Matthey's payout ratio is currently 130.84%.
Wall Street Analysts Forecast Growth
Several brokerages have commented on JMAT. Jefferies Financial Group restated a "buy" rating and issued a GBX 1,800 ($22.74) price objective on shares of Johnson Matthey in a report on Tuesday, December 17th. Berenberg Bank lowered their price objective on shares of Johnson Matthey from GBX 1,650 ($20.85) to GBX 1,500 ($18.95) and set a "hold" rating for the company in a report on Thursday, November 28th.
Check Out Our Latest Analysis on JMAT
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Featured Articles

Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.